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Background: Extracorporeal membranous oxygenation is proposed for abdominal organ procurement from
donation after circulatory determination of death (DCD). In France, the national Agency of Biomedicine supervises
the procurement of kidneys from DCD, specifying the durations of tolerated warm and cold ischemia. However, no
study has determined the optimal conditions of this technique. The aim of this work was to develop a preclinical
model of DCD using abdominal normothermic oxygenated recirculation (ANOR). In short, our objectives are to
characterize the mechanisms involved during ANOR and its impact on abdominal organs.
Methods: We used Large White pigs weighing between 45 and 55 kg. After 30 minutes of potassium-induced
cardiac arrest, the descending thoracic aorta was clamped and ANOR set up between the inferior vena cava and
the abdominal aorta for 4 hours. Hemodynamic, respiratory and biochemical parameters were collected. Blood
gasometry and biochemistry analysis were performed during the ANOR procedure.
Results: Six ANOR procedures were performed. The surgical procedure is described and intraoperative parameters
and biological data are presented. Pump flow rates were between 2.5 and 3 l/min. Hemodynamic, respiratory,
and biochemical objectives were achieved under reproducible conditions. Interestingly, animals remained
hemodynamically stable following the targeted protocol. Arterial pH was controlled, and natremia and renal
function remained stable 4 hours after the procedure was started. Decreased hemoglobin and serum proteins
levels, concomitant with increased lactate dehydrogenase activity, were observed as a consequence of the
surgery. The serum potassium level was increased, owing to the extracorporeal circulation circuit.
Conclusions: Our ANOR model is the closest to clinical conditions reported in the literature and will allow the
study of the systemic and abdominal organ impact of this technique. The translational relevance of the pig will
permit the determination of new biomarkers and protocols to improve DCD donor management.
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Transplantation is the best alternative to end-stage organ
disease [1]. The increasing number of patients waiting for
an organ has led transplant teams to consider new sources
of organs. A possible answer to this organ shortage is the
use of organs from donation after circulatory determin-
ation of death (DCD) [2]. Cardiac arrest may be unex-
pected (type I and II of the Maastricht classification), or
occur after life-sustaining care withdrawal (type III of the
Maastricht classification). One of the challenges of DCD
management is to correct or prevent ischemia-reperfusion
injury due to the unavoidable period of warm ischemia.
Warm ischemia is usually more pronounced in uncon-
trolled donation and it is of utmost importance to define
an effective method to limit it. As this method will be
applied after death certification in uncontrolled donors, it
will not raise the usual ethical concerns that can be
encountered in controlled donation.
In renal transplantation centers using kidneys from
DCD, it has been shown that this organ source could
increase the donor pool by 20 to 40% [3]. However, organs
from these donors are more prone to ischemia-reperfu-
sion injury because DCD kidneys suffer a period of
warm ischemic damage (no-flow and low-flow periods) in
addition to cold ischemia during ex-vivo conservation.
Consequently, the risk of primary nonfunction and de-
layed graft function is higher [4,5].
Methods for conditioning abdominal organs before
removal have evolved. Initially, protocols were limited to
in-situ cooling using an intra-aortic double balloon cath-
eter or Gillot’s catheter [6,7]. This technique is referred to
as cold in-situ perfusion. Since the middle of the 1990s,
normothermic extracorporeal membrane oxygenation has
been proposed, either in hypothermic conditions for total
body cooling or in normothermic conditions limited to
the abdomen using abdominal normothermic oxygenated
recirculation (ANOR). This method has been devel-
oped and applied by several groups around the world
[8-12]. This technique uses a normothermic extracorporealFigure 1 Recommendations for kidney removal from donation after car
ANOR, abdominal normothermic oxygenated recirculation.membrane oxygenation circuit with cannulae introduced
by a femoral approach and an occlusive balloon positioned
in the descending thoracic aorta to limit circulation to the
abdominal region.
In France, a national protocol was designed to use
exclusively uncontrolled donors (DCD type II of the
Maastricht classification). The program started in 2007
and the protocol is summarized in Figure 1 [13]. In 2000,
a team from Barcelona compared kidney preservation
with cold in-situ perfusion, hypothermic cardiopulmonary
bypass, and ANOR [8]. A significant decrease in primary
nonfunction and delayed graft function with satisfactory
long-term graft survival was identified for the ANOR
group. Several other groups have reported their experi-
ences with ANOR in uncontrolled and controlled donors
and suggested the superiority of ANOR in DCD, as com-
pared with cold in-situ perfusion (for a review, see [14]).
However, no formal demonstration has been established.
Many issues remain to be addressed regarding the ideal
protocol, such as ideal temperature and optimal duration.
The use of additives is also a pivotal question. Clearly, ex-
perimental work is mandatory to better define the optimal
conditions of this technique, which will help to limit or
even repair the injuries induced by warm ischemia. The
aim of our work was to develop a preclinical model
of DCD based on the current recommendations of the
French national regulatory authority on the study of kid-
neys exposed to ANOR and to optimize the conditions
under which the technique is used.
Methods
Experimental model
The protocol was carried out in accordance with the regu-
lations of the French Ministry of Agriculture, the National
Institute for Agronomic Research and the regional ethics
committee on animal experiments (Comité d’éthique pour
l’expérimentation animale en Poitou-Charentes). The ani-
mals were Large White male pigs about 3 months old and
weighing between 45 and 55 kg. These animals have beendiac death according to the French national regulatory authority.
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to study ischemia-reperfusion injuries with renal trans-
plantation models [15,16]. The pig is well suited for pre-
clinical studies because its anatomy and physiology
are very similar to those of human beings and it has
rapidly been chosen for potential applications in clinical
practice [17].
We used a Rotaflow Maquet centrifugal pump with
Softline Coating Maquet-Jostra pre-heparinized circuit
(Maquet Cardiopulmonary AG, Hirrlingen, Germany). A
thermoregulatory system is connected to maintain a tem-
perature of 37°C. The circuit is purged with hydroxyethy-
lamide (Restorvol® 6%, Fresenius Kabi, Sèvres, France).
The priming is approximately 700 to 800 cm3.
Anesthetic procedure
Induction of the animal is performed with a Hunter
mask with a mixture of nitrous oxide and oxygen 50/50
associated with 8% sevoflurane then 2.5% isoflurane. A
perfusion line is set at a marginal vein of the ear. Orotra-
cheal intubation is performed under laryngoscopic con-
trol. Controlled ventilation is performed with a respiratory
rate of 16/min while maintaining expired CO2 between 35
and 45 mmHg. Curarization of the animal is performed by
initial injection of 8 mg pancuronium bromide followed
by reinjection adapted to the behavior of the animal. Intra-
operative analgesia is achieved by intravenous injections
of 20 mg nalbuphine and 20 mg nefopam.
Surgical procedure
A video of the procedure is provided in Additional file 1.
The animal is placed supine with access to the cervical,
thoracic, and abdominal regions (Figure 2). First, a central
venous catheter is positioned in the internal jugular vein
after right cervicotomy. Then, laparotomy is performed.
The abdominal aorta and inferior vena cava under the
renal vessels are dissected, since the femoral vessels are
too small to receive cannulae of sufficient size to ensureFigure 2 Installation of the animal for the procedure.the flow rate used. We chose an extraperitoneal approach
to avoid lymphatic losses and to limit vascular filling and
hemodilution. Indeed, the formation of a third sector is
frequently encountered in renal transplants performed by
a transperitoneal approach in the laboratory. A bolus of
300 IU/kg of unfractionated heparin is injected through
the central venous catheter. This dosage is recommen-
ded by the French national regulatory authority. After
5 minutes, a 14 Fr arterial cannula (Medtronic Inc.,
Minneapolis, MN) is placed in the abdominal aorta under
the renal arteries and a 21 Fr long multiperforated venous
cannula (Medtronic Inc., Minneapolis, MN) is posi-
tioned at the junction of the inferior vena cava and the
right auricle (Figure 3). Cannulae are introduced ac-
cording to the Seldinger technique, so as to be com-
pletely sealed.
Injection of 2 g potassium chloride by the central
venous catheter leads to cardiac arrest. Mechanical
ventilation is stopped. The descending thoracic aorta
is approached by a short left thoracotomy so as to be
clamped (Figure 4). Another catheter is placed down-
stream from the clamp to monitor blood pressure.
The laboratory model is shown schematically in Figure 5.
After 30 minutes of warm ischemia, ANOR is started for
4 hours.
Abdominal normothermic oxygenated recirculation:Procedure, progression, and data collection
Monitoring procedures with objectives and corrective
actions are summarized in Table 1. Blood samples are
collected via the central venous catheter before laparot-
omy and every hour during the ANOR on the arterial
line. Plasmas from heparinized blood are stored for later
biochemical analysis. At the end of 4 hours, kidneys are
explanted and stored for later analysis. The ANOR is
stopped. Cannulae and catheters are removed and the
animal is euthanized.Figure 3 Cannulation of aorta and inferior vena cava under
renal vessels by an extraperitoneal approach.
Figure 4 Aortic clamping and arterial catheter through left
thoracotomy.
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The pump flow rate was monitored continuously during
the procedure. The arterial pressure and central venous
pressure were measured continuously during ANOR
using a monitor HP 56S (Hewlett-Packard, Les Ulis,
France). The partial pressures of oxygen and carbon
dioxide, the fraction of inspired oxygen, and the pH
were measured every 30 minutes during the procedure,
using an i-STAT portable clinical analyzer (Hewlett-
Packard, Les Ulis, France). The activated clotting time
was also measured every 30 minutes, using a Hemostasis
Management System (Medtronic, Boulogne-Billancourt,
France).Figure 5 Abdominal normothermic oxygenated recirculation in the p
C, arterial catheter; CP, centrifugal pump; D, diaphragm; E, venous canulae
H, gas entry; LH, left heart; LK, left kidney; OM, oxygenation membrane; RHLevels of plasma potassium, sodium, protein, lactate de-
hydrogenase (as an acidosis marker), and blood hemoglobin
were quantified every hour during the ANOR procedure
using an automated chemistry analyzer (Modular, Roche
Diagnostics, France). To determine renal function, plasma
creatinine was measured every hour during the ANOR,
again using an automated chemistry analyzer (Modular,
Roche Diagnostics, France).
Statistical analysis
Results are expressed as mean ± standard deviation. For
the statistical analysis among groups, we used NCSS
software (NCSS LLC, USA) and ANOVA or two-sample
t test analysis in the case of normality (skewness, kurtosis,
and omnibus tests) and equality of variance (modified
Levene equal-variance test) and the Mann–Whitney U
test or Kruskal-Wallis test for multiple comparison
analysis where these parameters were not met. Dif-
ferences with a P value of less than 0.05 were considered
significant.
Results and discussion
Monitored parameters during abdominal normothermic
oxygenated recirculation
Six 4-hour ANOR procedures were performed. Animal
weight varied between 45 and 55 kg. The monitored
parameters and objectives are listed in Table 1.
Results for the monitored parameters are expressed as
mean ± standard deviation (Table 2). The pump flow
rate, mean arterial pressure, and central venous pressurereclinical porcine model. A, central venous catheter; B, aortic clamp;
in inferior vena cava; F, arterial canulae in aorta; G, perfusion entry;
, right heart; RK, right kidney; TS, thermoregulatory system.
Table 1 Monitoring procedures during abdominal normothermic oxygenated recirculation
Monitored parameters Objectives Type of monitoring Corrective actions
Pump flow rate 2.5 to 3 l/min Continuous monitoring Vascular filling: saline and hydroxyethyl
starch (10 ml/(kg h))
Mean arterial pressure >60 mmHg Continuous infusion of noradrenalin on the circuit
Central venous pressure <5 mmHg —
pH 7.5 Blood samples on the circuit
every 30 minutes
Continuous infusion of sodium bicarbonate on the circuit
Partial pressure of carbon dioxide 30 to 40 mmHg Sweeping gas flow adjustment
Partial pressure of oxygen 100 to 150 mmHg Fraction of inspired oxygen adjustment
Activated clotting time >200 s Bolus of 5000 IU unfractionated heparin on the circuit
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ure. Partial pressures of oxygen and of carbon dioxide
were stabilized during the procedure, between 122 and
173 mmHg and between 30 and 37 mmHg, respectively.
There was an exception for activated clotting time,
which was rarely above 200 s. It was therefore often
necessary to inject 5000 IU unfractionated heparin every
30 minutes during the ANOR process. The objectives,
listed in Table 1, were achieved under reproducible
conditions.
Evolution of biological parameters during abdominal
normothermic oxygenated recirculation
The evolution of biological parameters during ANOR
is summarized in Table 3. There was no significant differ-
ence between T0 and 4 hours of ANOR for pH (7.4 ± 0.01
to 7.4 ± 0.03, respectively), serum sodium concentration
(138 ± 1 to 138 ± 1 mmol/l, respectively), serum creatinine
concentration (99 ± 6 to 129 ± 27 μmol/l, respectively).
Lactate dehydrogenase activity was significantly increased
between T0 and 4 hours (714 ± 48 to 1041 ± 204 IU/l,
respectively), and was probably related to the stresses of
the surgery and muscular attrition. Serum protein and
hemoglobin levels showed significant decrease between
T0 and 4 hours of ANOR, demonstrating hemodilution
and bleeding during surgery (56 ± 3 to 37 ± 3 g/l for serumTable 2 Comparison of monitored parameters during abdomina
deviation)
ANOR 1 ANOR
Weight (kg) 49 51
Pump flow rate (l/min) 2.5 ± 0.03 2.5 ± 0.0
Mean arterial pressure (mmHg) 65 ± 6 64 ± 5
Noradrenalin (μg/(kg min)) 0.7 ± 0.05 1.1 ± 0.1
Fraction of inspired oxygen (%) 56 ± 3 62 ± 5
Partial pressure of oxygen (mmHg) 123 ± 25 122 ± 1
Sweeping gas flow (l/min) 3.2 ± 0.2 4 ± 0
Partial pressure of carbon dioxide (mmHg) 37 ± 5 35 ± 1
Activated clotting time (s) 174 ± 32 183 ± 2
ANOR, abdominal normothermic oxygenated recirculation.protein concentration and 12 ± 0.1 to 9.3 ± 0.6 g/dl for
hemoglobin level). Correction of serum potassium levels
was not perfect, with lower levels at 4 hours than at 1 hour;
however, they remained significantly higher than at T0.
This was due to the extracorporeal circulation circuit.
Discussion
The increasing demand for transplantation has created a
need for additional organ sources, and acceptance cri-
teria have been widened, not only for kidney retrieval
but increasingly for other organs with a lower tolerance
of warm ischemia, such as the liver, pancreas, and lungs
[18,19]. This expansion of donor criteria to include the
use of grafts from elderly donors, DCD, or organs from
donors with other medical conditions has underlined the
need for a technique that prevents any further damage
during the preservation period. Previous reports strongly
suggest that DCD donors are a valuable source of organs
[3,14,20,21]. Reconditioning using ANOR appears to
give better results than in-situ cooling preservation, with
a reduction of primary nonfunction and delayed graft
function [8]. In France, the national regulatory authority
(Agence de la Biomédecine) has defined the conditions for
organ removal, specifying the tolerated durations of warm
and cold ischemia, for uncontrolled donors (type II of the
Maastricht classification). However, no preliminary studyl normothermic oxygenated recirculation (mean ± standard
2 ANOR 3 ANOR 4 ANOR 5 ANOR 6
55 45 50 45
3 2.8 ± 0.03 2.7 ± 0.05 2.6 ± 0.05 2.5 ± 0.03
84 ± 3 86 ± 10 77 ± 3 75 ± 6
9 0.6 ± 0.08 0.6 ± 0.2 0.6 ± 0.07 0.7 ± 0.15
59 ± 5 45 ± 2 54 ± 1 56 ± 3
6 141 ± 27 173 ± 31 149 ± 13 151 ± 19
4.3 ± 0.2 3.3 ± 0.2 3.6 ± 0.1 3.5 ± 0
35 ± 1 32 ± 2 30 ± 1 31 ± 1
7 180 ± 21 198 ± 33 173 ± 20 171 ± 20
Table 3 Evolution of biological parameters during abdominal normothermic oxygenated recirculation (means ± standard
deviation)
T0 1 hour 2 hours 3 hours 4 hours P T0 versus 4 hours
pH 7.4 ± 0.01 7.42 ± 0.06 7.42 ± 0.03 7.40 ± 0.05 7.44 ± 0.03 0.1795
Serum potassium (mmol/l) 4.1 ± 0.2 7.1 ± 0.5 7.9 ± 0.3 7.3 ± 0.5 6.8 ± 0.6 0.0002*
Serum sodium (mmol/l) 138 ± 1 136 ± 1 139 ± 1 137 ± 2 139 ± 3 0.4825
Serum protein (g/l) 56 ± 3 41 ± 3 45 ± 2 39 ± 2 37 ± 3 0.0002*
Hemoglobin (g/dl) 12 ± 0.1 10.9 ± 0.5 11.1 ± 0.5 10.1 ± 0.8 9.3 ± 0.6 0.0001*
Creatinine (μmol/l) 99 ± 6 130 ± 5 132 ± 18 133 ± 21 129 ± 27 0.1673
Lactate dehydrogenase (IU/l) 714 ± 48 1,036 ± 193 1,354 ± 133 1,132 ± 233 1,041 ± 204 0.0424*
*: statistically significant.
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sequently, there is room for experimental studies to
decipher the different steps of the protocol.
The development of a porcine preclinical experimental
model of DCD donors allows for a study of the ANOR
impact on organs without the limitations of a clinical
study. Several models of DCD donors have previously
been published in the literature to study the conditioning
of kidney transplants by normothermic perfusion. Re-
cently, using rats of 300 g and a warm ischemia period
corresponding to clamping of the renal artery for 15
or 30 minutes, Moers et al. studied reperfusion for 1
to 2 hours [22]. However, the restored pulsatile flow
was far from comparable to a continuous flow of ANOR.
In 2008, Hosgood et al. used a Large White pig model
weighing between 40 and 50 kg [23]. In this model, after
25 minutes of warm ischemia, kidneys were reperfused
normothermically for 3 hours in an isolated organ pre-
servation system using autologous blood. However, this
experimental condition remains far from a clinical situ-
ation. In 2010, Rojas-Pena et al. used an extracorporeal
membrane oxygenation circuit with pigs from 25 to 30 kg
[24]. Both external jugular veins were cannulated in place
of the inferior vena cava. In addition, the absence of
clamping of the descending thoracic aorta mimicked a
systemic circulation model, which was not exactly the
ANOR condition. The durations of warm ischemia were
10 and 30 minutes, respectively, and 90 and 100 minutes
for reperfusion.
To our knowledge, the uncontrolled DCD model pre-
sented herein is the closest to the conditions encoun-
tered in clinical practice. Indeed, we use a large animal,
the pig, well accepted as a preclinical model with a size,
anatomy, and cardiovascular physiology very similar
to those of human beings. Our model also used truly
regional circulation between the inferior vena cava and
the abdominal aorta, which was limited to the subdiaph-
ragmatic region by clamping of the descending thoracic
aorta. Moreover, our model is highly reproducible. In all
cases, hemodynamic and respiratory objectives were
achieved with very similar conditions from one animal toanother. After 4 hours of ANOR, there was no significant
difference compared with T0 for pH and plasma sodium
levels. Lactose dehydrogenase levels were increased, a sign
of tissue damage that was probably due to the stresses of
surgery (incisions, muscular attrition, and so on); the lack
of change between 1 and 4 hours of ANOR highlight the
fact that this marker is not adapted for discriminant
diagnosis determination. We observed an expected hemo-
dilution, mainly due to the ANOR priming (about 700 to
800 cm3). However, hemoglobin levels remained correct,
at 9.3 ± 0.6 g/dl after 4 hours of ANOR. Interestingly, in
our hands, renal function likewise remained stable during
ANOR and reached a steady state during the procedure.
However, the injection of heparin before cardiac arrest
is a critical limit in this model. We aim to correct this
easily in future protocols. Note that in previously descri-
bed models, injection of heparin was likewise carried out
before cardiac arrest.
It would also have been interesting to monitor urine
production during ANOR. However, bladder catheteriza-
tion of Large White male pigs is not possible, owing
to a tortuous urethra and we consequently chose not
to approach the bladder surgically, thereby avoiding
the opening of the peritoneum and fluid, particularly
lymph fluid, accumulation. However, we noted that at the
end of ANOR, urine (about 500 cm3) was collected in the
bladder. To better monitor kidney function, the implant-
ation of a urine catheter during ANOR is envisioned for
future experiments.
Conclusions
We developed a preclinical experimental model of uncon-
trolled DCD kidneys donors using ANOR. This model will
allow the development of experimental procedures and
the study of systemic and renal impact of the ANOR at
different steps. Many issues could be addressed, such as
optimal temperature and duration. This model could help
to tailor strategies and to build clinical protocols for pres-
ervation and viability prediction and evaluate preservation
protocols following ANOR. It is ideal to determine the
optimal conditions for pre- and post-conditioning, which
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parative studies between ANOR and in-situ cooling pres-
ervation. This model can also facilitate the study of
conditioning protocols for other abdominal organs with
ANOR and the effect of additives on ischemia-reperfusion
injury. The translational relevance of the pig also permits
the study of relevant biomarkers for real-time evaluation
of organ viability during and after ANOR. Finally, the
technology is readily available and easy to handle with a
relatively short learning curve. Such programs could be
included in transplantation operative procedures and sur-
gical skills taught to young European surgeons entering
the field of transplantation surgery.
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Additional file 1: Video of surgical procedure.
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